Mechanism of Action — PT-141 vs Kisspeptin
PT-141 (bremelanotide) is a cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone ( -MSH) with selective agonist activity at melanocortin MC3R and MC4R receptors. These receptors are densely expressed in the paraventricular nucleus (PVN) of the hy
This comparison does not assign a generated winner or score.
- PT-141 (bremelanotide) is a cyclic heptapeptide analog of alpha-melanocyte-stimulating hormone (α-MSH) with selective agonist activity at melanocortin MC3R and MC4R receptors. These receptors are densely expressed in the paraventricular nucleus (PVN) of the hypothalamus and the ventromedial hypothalamus (VMH). Brain regions that mediate sexual motivation and autonomic arousal. PT-141 does not act peripherally on vascular smooth muscle (unlike PDE5 inhibitors) and does not influence circulating androgen levels. Its effect is purely central: activating neural circuits associated with desire, motivation, and arousal signaling. The half-life of subcutaneously administered PT-141 is approximately 2.7 hours, with peak plasma concentration occurring 45–60 minutes post-injection.
- Kisspeptin-10 is a decapeptide fragment of the 145-amino-acid precursor kisspeptin protein, encoded by the KISS1 gene. It binds with nanomolar affinity to GPR54 (also called KISS1R), a G-protein-coupled receptor expressed on GnRH neurons in the arcuate nucleus and anteroventral periventricular nucleus (AVPV) of the hypothalamus. Kisspeptin binding triggers rapid depolarization of GnRH neurons and sustained increases in GnRH pulse frequency. The upstream signal that drives pituitary LH secretion. LH, in turn, stimulates Leydig cells in the testes to produce testosterone. Kisspeptin has a plasma half-life of 27–30 minutes when administered subcutaneously, with peak GnRH pulse elevation occurring within 30–90 minutes. Unlike PT-141, kisspeptin's effect is hormonal. It modulates the HPG axis, not central arousal circuits.
- The key distinction: PT-141 activates arousal-related neural circuits independent of gonadal hormone levels. Kisspeptin restores or amplifies GnRH pulsatility, which in turn elevates LH and testosterone. Real Peptides supplies both peptides as lyophilized powders synthesized under exact amino-acid sequencing to ensure receptor binding fidelity. Any structural deviation from the native sequence eliminates activity.